(Q39368100)

English

Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Paromita Kundu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chandana Mohanty

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sanjeeb K Sahoo

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

4 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Acta Biomaterialia

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

2670-2687

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.08.010

Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2011.06.015

Stat3 as an oncogene

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Telomerase and cancer therapeutics

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Pluronic block copolymers: novel functional molecules for gene therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Blood-brain interfaces and cerebral drug bioavailability

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Effects of Curcuma spp. on P-glycoprotein function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

[Study of resistance to chemotherapy mediated by ABC transporters in biopsies of glioblastoma multiforme].

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

New strategies to deliver anticancer drugs to brain tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Nanotech approaches to drug delivery and imaging

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Nanoparticulate systems for brain delivery of drugs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Bioavailability of curcumin: problems and promises

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

The blood-brain barrier: an overview: structure, regulation, and clinical implications

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Neurodegenerative disorders and nanoformulated drug development

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

NanoART, neuroAIDS and CNS drug delivery

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

"Spicing up" of the immune system by curcumin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin: the Indian solid gold

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Cancer nanotechnology: application of nanotechnology in cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1).

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Nano-interventions for neurodegenerative disorders

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Malignant astrocytic glioma: genetics, biology, and paths to treatment

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2012.03.048

Identifiers

10.1016/J.ACTBIO.2012.03.048

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

release_txgugorr2fdp7duiawklfhxpve

1 reference

https://api.fatcat.wiki/v0/release/txgugorr2fdp7duiawklfhxpve

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39368100&oldid=2097476495"